South America In Vitro Diagnostics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Instruments, Reagents, Software), By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others), By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others), By End Use (Hospitals, Laboratory, Home care, Others), By Region, By Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 5.93 billion

CAGR (2023-2028)

1.42%

Fastest Growing Segment

Reagents

Largest Market

Brazil

 

Market Overview

South America In Vitro Diagnostics Market has valued at USD 5.93 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 1.42% through 2028. The South America In Vitro Diagnostics (IVD) market is experiencing substantial growth due to several key factors. These include a expanding population, supportive government insurance policies, and enhanced healthcare infrastructure. Additionally, the market stands to benefit significantly from the increasing number of elderly individuals who are more susceptible to infections. For instance, Chile is projected to witness a twofold increase in its population aged 65 and above between 2010 and 2030, contributing to the market's growth potential.

Key Market Drivers

Rising Population and Healthcare Needs

The field of in vitro diagnostics (IVD) in South America is experiencing a significant growth trajectory, and one of the prominent drivers behind this expansion is the rising population in the region, coupled with the increasing healthcare needs of its inhabitants. South America is a diverse and dynamic continent, home to a variety of healthcare challenges and opportunities.

South America is witnessing a remarkable surge in its population. This demographic trend is, in itself, a substantial contributor to the growth of the IVD market. With more people residing in the region, the demand for healthcare services is on the rise. As a consequence, healthcare providers are grappling with a larger patient pool, and this heightened demand for medical services naturally extends to diagnostic procedures.

A growing population necessitates a more comprehensive healthcare infrastructure. In this scenario, in vitro diagnostics play a pivotal role in early detection and prevention. These diagnostic tests are vital for identifying diseases, monitoring health conditions, and guiding treatment decisions. With more people seeking medical care, the need for accurate and timely diagnostic testing becomes paramount.

An increasing population is often accompanied by a stronger emphasis on healthcare accessibility. Governments and private healthcare providers in South America are striving to make healthcare services more readily available to their citizens. This includes expanding the reach of healthcare facilities, clinics, and laboratories across urban and rural areas. In vitro diagnostics are integral to these services, facilitating swift and accurate diagnoses that can lead to more effective treatments.

The rising population in South America is also experiencing changes in lifestyle and dietary habits. As a result, there is a higher prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. In vitro diagnostics, including blood tests and biomarker assessments, are crucial for diagnosing and managing these conditions. Their role in early intervention and ongoing monitoring cannot be overstated.

Governments across South America are increasingly recognizing the importance of IVD in their healthcare systems. Healthcare policies are evolving to accommodate the changing needs of the population, with a focus on promoting preventative healthcare, timely intervention, and improved patient outcomes. This policy support often includes investments in healthcare infrastructure and diagnostic services, further driving the growth of the IVD market.

The healthcare sector is embracing technological advancements, and the IVD market is no exception. Innovative diagnostic tools and processes are emerging, providing more accurate and efficient diagnostic solutions. These advancements are not only beneficial for healthcare professionals but also for patients who expect more precise diagnoses and tailored treatment plans.

Favorable Government Policies

The In Vitro Diagnostics (IVD) market in South America is experiencing a remarkable surge, and one of the critical factors propelling this growth is the active role of governments in the region. Favorable government policies have become a catalyst for the expansion of the IVD market, fostering an environment that supports innovation, accessibility, and the improvement of healthcare services.

One of the fundamental ways in which governments are boosting the IVD market is by investing in healthcare infrastructure. South American governments are actively expanding and upgrading healthcare facilities, including diagnostic laboratories and medical clinics. This infrastructure development creates more opportunities for IVD services and encourages healthcare providers to invest in advanced diagnostic equipment, thereby improving the quality of healthcare delivery.

Governments in South America are increasingly recognizing the importance of research and development in healthcare, particularly in the field of diagnostics. By funding research and innovation, governments are helping local companies and institutions develop cutting-edge diagnostic technologies. This support leads to the creation of novel diagnostic tests and devices that not only meet domestic healthcare needs but can also be exported, boosting the region's IVD market on a global scale.

Favorable government policies often include initiatives aimed at training healthcare professionals. These programs focus on enhancing the skills of laboratory technicians, pathologists, and other healthcare workers involved in IVD procedures. The result is a skilled workforce that can effectively use advanced diagnostic equipment and perform high-quality diagnostic tests, leading to better patient outcomes.

Governments are taking measures to ensure that diagnostic services meet high standards of quality and safety. This includes implementing regulations and standards that IVD companies must adhere to. By promoting quality assurance and stringent regulatory oversight, governments are instilling confidence in the reliability of diagnostic tests. Patients and healthcare professionals alike benefit from these policies, which further stimulate the growth of the IVD market.

Government-led public health initiatives are driving the demand for diagnostic services. These initiatives often target specific diseases, such as HIV/AIDS, tuberculosis, or maternal and child health. By promoting testing and early detection, governments are not only improving healthcare outcomes but also creating a steady demand for IVD tests and equipment, thereby fostering market growth.

Favorable government policies often focus on making healthcare more affordable and accessible to a broader segment of the population. This includes subsidizing diagnostic tests and expanding health insurance coverage. As a result, more people can access diagnostic services, which leads to increased demand for IVD procedures, further fueling market growth.

Aging Population

The South America In Vitro Diagnostics (IVD) market is experiencing a surge in growth, and one of the prominent catalysts behind this expansion is the region's rapidly aging population. As South America witnesses a demographic shift towards an older population, the demand for healthcare services, including diagnostic testing, is on the rise.

With advancing age come various health challenges. South America is seeing a significant increase in its elderly population, many of whom face a higher risk of chronic diseases and age-related conditions. This includes conditions such as diabetes, cardiovascular disease, and cancer, which require regular monitoring and early detection. As a result, the demand for diagnostic tests, such as blood tests and imaging, has surged, fueling the growth of the IVD market.

Elderly individuals often have a higher incidence of chronic conditions. Diagnostic tests play a critical role in managing and monitoring these health conditions. Frequent tests to measure blood sugar levels, cholesterol, and other biomarkers become a routine part of healthcare for the elderly. As the aging population continues to grow, so does the need for these tests, making IVD a vital component of healthcare services.

Early detection of diseases and health conditions is a key factor in improving the health and well-being of elderly individuals. IVD tests are instrumental in identifying health issues at their earliest stages, allowing for timely intervention and treatment. This not only improves the quality of life for older individuals but also reduces the burden on healthcare systems. Governments and healthcare providers in South America are recognizing the importance of early detection and prevention, further boosting the demand for IVD tests.

As the population ages, there is a growing need for specialized diagnostics to address age-related health concerns. For example, bone density tests to detect osteoporosis, Alzheimer's disease biomarker testing, and cardiovascular diagnostics tailored to the elderly are becoming more prevalent. The IVD market responds by developing and offering these specialized tests, meeting the specific healthcare needs of the aging population.

Advancements in IVD technology have led to the development of user-friendly, home-based diagnostic kits. These kits enable older adults to monitor their health from the comfort of their homes, reducing the need for frequent hospital visits. The ease of use and accessibility of these home-based tests align with the preferences of many elderly individuals, further promoting the growth of the IVD market.

Increased Awareness

The In Vitro Diagnostics (IVD) market in South America is experiencing a notable upswing, with increased awareness among both healthcare professionals and the general population emerging as a driving force behind this growth.

One of the keyways in which increased awareness is fostering growth in the IVD market is by promoting preventative healthcare. As healthcare providers and public health campaigns emphasize the significance of early detection and regular health check-ups, more individuals are proactively seeking diagnostic tests. This cultural shift toward preventative care not only enhances health outcomes but also creates a surge in the demand for IVD tests.

Heightened awareness about specific diseases and their risk factors encourages individuals to undergo routine screening. For instance, campaigns educating the public about the dangers of conditions like diabetes, cancer, and cardiovascular diseases have spurred more people to seek early diagnostic tests. This proactive approach to health increases the volume of diagnostic procedures, stimulating the growth of the IVD market.

Increased awareness has led to a greater focus on making diagnostic testing accessible and convenient for the general population. As individuals become more informed about their health, they also seek convenient options for getting tested. This trend has driven the development of home-based and point-of-care diagnostic solutions, making it easier for people to access essential tests and promoting market growth.

Government-driven public health initiatives have played a significant role in raising awareness about various health issues. These initiatives include mass screenings, awareness campaigns, and education about the importance of regular check-ups. By providing information and resources, governments are not only improving the overall health of the population but also driving up the demand for diagnostic testing.

Increased awareness extends to healthcare professionals, who are continuously updated about the latest diagnostic tools and technologies. As healthcare professionals become more knowledgeable about the benefits of IVD tests and their role in patient care, they are more likely to recommend and conduct these tests, contributing to the growth of the IVD market.

Awareness campaigns and educational efforts have empowered patients to take an active role in their healthcare decisions. Informed patients are more likely to request diagnostic tests, question their healthcare providers, and seek second opinions when necessary. This shift towards increased patient engagement in healthcare is boosting the demand for diagnostic tests.

Download Free Sample Report

 

Key Market Challenges

Economic Disparities

Economic disparities across South America present a significant challenge for the IVD market. Many countries in the region face income inequality, which affects healthcare access and the affordability of diagnostic tests. The high cost of advanced IVD equipment and tests may limit their availability to a broader population, hindering the market's growth potential.

Cultural and Language Diversity

South America is known for its cultural and linguistic diversity. Different regions within countries often have distinct languages and cultural practices. This diversity can pose challenges in healthcare communication and the interpretation of diagnostic results, especially in remote or indigenous communities.

Limited Healthcare Budgets

Many South American countries face constraints in their healthcare budgets. Limited financial resources can restrict investments in healthcare infrastructure and the purchase of IVD equipment. As a result, healthcare providers may struggle to provide comprehensive diagnostic services, impacting the market's growth.

Key Market Trends

Point-of-Care Testing (POCT)

Point-of-care testing is gaining momentum in South America. This trend reflects the shift towards more convenient, rapid, and accessible diagnostic solutions. POCT allows for testing at or near the patient, reducing the time and cost associated with sending samples to central laboratories. This is particularly valuable in remote or underserved areas and for routine monitoring of chronic diseases.

Growth in Infectious Disease Testing

The COVID-19 pandemic has heightened the importance of infectious disease testing. South America is expected to see an increased focus on infectious disease diagnostics, including improved testing capabilities for COVID-19 and other prevalent diseases in the region, such as dengue, Zika, and Chagas disease.

Advanced Diagnostic Technologies

South America is experiencing a growing interest in advanced diagnostic technologies, such as next-generation sequencing, liquid biopsy, and advanced imaging. These innovations enable more precise and early detection of diseases, including cancer and genetic disorders. As these technologies become more accessible, they will reshape the IVD market.

Segmental Insights

Product Insights

In 2022, the reagents category held the largest market share and is projected to experience the most rapid CAGR throughout the forecasted period. The substantial share in this segment can be attributed to its increasing utilization in diverse sectors, including academic institutions, healthcare facilities, and clinical laboratories. Furthermore, technological advancements and increased investments by market participants in the development of new products have created favorable opportunities for the expansion of the instruments market during the forecast period.

Application Insights

In the South America in-vitro diagnostics market of 2022, the infectious diseases category captured the largest portion of revenue. This dominant market share can be attributed to the rising prevalence of infectious diseases and a limited awareness of hygienic practices in Latin American nations. Notably, the incidence of vector-borne diseases like dengue, hemorrhagic fever, and yellow fever has remained persistently high since 1995, occurring at twice the average rate. Collaborative efforts by the Pan American Health Organization and the World Health Organization (WHO) aim to combat infectious diseases in this region.

Conversely, the oncology segment is expected to experience substantial growth during the forecasted period. This growth is driven by an increase in cancer cases, government initiatives promoting early detection, and an improved level of public awareness. According to a June 2022 article published by the International Agency for Research on Cancer, which operates under the World Health Organization, Latin America reported approximately 1.5 million new cancer cases and 700,000 cancer-related deaths.

Download Free Sample Report

Regional Insights

Brazil is poised to take the lead in the South America In Vitro Diagnostics Market for several compelling reasons. First, Brazil boasts a substantial population and a robust healthcare infrastructure, making it a significant contributor to the region's healthcare demand. The country's healthcare industry is witnessing continuous advancements, with a focus on improving diagnostic technologies and accessibility to healthcare services. Furthermore, Brazil's diverse healthcare ecosystem caters to both public and private sectors, facilitating market growth. Additionally, government initiatives and policies that promote healthcare investments and research are fostering a conducive environment for the In Vitro Diagnostics industry. With its combination of a large market size, evolving healthcare infrastructure, and proactive government support, Brazil is well-positioned to dominate the South American In Vitro Diagnostics Market.

Recent Developments

  • In February 2023, Roche Diagnostics unveiled a partnership with the U.S. Centers for Disease Control and Prevention (CDC) geared towards enhancing laboratory systems with the goal of improving the quality and availability of testing services in Central America, Latin America, the Caribbean, as well as various nations in Africa, Eastern Europe, and Central Asia. This collaboration will operate as a public-private partnership (PPP) and will focus on efforts to prevent the transmission of the human immunodeficiency virus (HIV) and tuberculosis (TB) within the specified regions.

Key Market Players

  • Becton Dickinson & Co Ltd
  • BIOMÉRIEUX SA
  • Abbott Laboratories Inc
  • Quidel Corp
  • OraSure Technologies, Inc.
  • Hologic Inc
  • Cepheid
  • QIAGEN NV
  • F Hoffmann-La Roche AG
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories Inc

 By Product

By Technology

By Application

By End Use

By Region
  • Instruments
  • Reagents
  • Software
  • Immunoassay
  • Hematology
  • Clinical chemistry
  • Molecular diagnostics
  • Coagulation
  • Microbiology
  • Others
  • Infectious diseases
  • Diabetes
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune diseases
  • Drug testing
  • Others
  • Hospitals
  • Laboratory
  • Home care
  • Others
  • Brazil
  • Chile
  • Peru
  • Colombia
  • Argentina
  • Venezuela
  • Bolivia
  • Ecuador
  • Paraguay
  • Uruguay

 

Report Scope:

In this report, the South America In Vitro Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • South America In Vitro Diagnostics Market, By Product:

o   Instruments

o   Reagents

o   Software

  • South America In Vitro Diagnostics Market, By Technology:

o   Immunoassay

o   Hematology

o   Clinical chemistry

o   Molecular diagnostics

o   Coagulation

o   Microbiology

o   Others

  • South America In Vitro Diagnostics Market, By Application:

o   Infectious diseases

o   Diabetes

o   Oncology/Cancer

o   Cardiology

o   Nephrology

o   Autoimmune diseases

o   Drug testing

o   Others

  • South America In Vitro Diagnostics Market, By End Use:

o   Hospitals

o   Laboratory

o   Home care

o   Others

  • South America In Vitro Diagnostics Market, By Region:

o   Brazil

o   Chile

o   Peru

o   Colombia

o   Argentina

o   Venezuela

o   Bolivia

o   Ecuador

o   Paraguay

o   Uruguay

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the South America In Vitro Diagnostics Market.

Available Customizations:

South America In Vitro Diagnostics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

South America In Vitro Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]               

Table of content

1.    Service Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    South America In Vitro Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Instruments, Reagents, Software)

5.2.2.     By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

5.2.3.     By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

5.2.4.     By End Use (Hospitals, Laboratory, Home care, Others)

5.2.5.     By Region

5.2.6.     By Company (2022)

5.3.  Product Market Map

5.3.1.     By Product

5.3.2.     By Technology

5.3.3.     By Application

5.3.4.     By End Use

5.3.5.     By Region

6.    Brazil In Vitro Diagnostics Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Instruments, Reagents, Software)

6.2.2.     By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

6.2.3.     By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

6.2.4.     By End Use (Hospitals, Laboratory, Home care, Others)

7.    Chile In Vitro Diagnostics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Instruments, Reagents, Software)

7.2.2.     By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

7.2.3.     By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

7.2.4.     By End Use (Hospitals, Laboratory, Home care, Others)

8.    Peru In Vitro Diagnostics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product (Instruments, Reagents, Software)

8.2.2.     By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

8.2.3.     By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

8.2.4.     By End Use (Hospitals, Laboratory, Home care, Others)

9.    Colombia In Vitro Diagnostics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product (Instruments, Reagents, Software)

9.2.2.     By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

9.2.3.     By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

9.2.4.     By End Use (Hospitals, Laboratory, Home care, Others)

10.  Argentina In Vitro Diagnostics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product (Instruments, Reagents, Software)

10.2.2.  By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

10.2.3.  By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

10.2.4.  By End Use (Hospitals, Laboratory, Home care, Others)

11.  Venezuela In Vitro Diagnostics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product (Instruments, Reagents, Software)

11.2.2.  By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

11.2.3.  By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

11.2.4.  By End Use (Hospitals, Laboratory, Home care, Others)

12.  Bolivia In Vitro Diagnostics Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Product (Instruments, Reagents, Software)

12.2.2.  By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

12.2.3.  By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

12.2.4.  By End Use (Hospitals, Laboratory, Home care, Others)

13.  Ecuador In Vitro Diagnostics Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Product (Instruments, Reagents, Software)

13.2.2.  By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

13.2.3.  By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

13.2.4.  By End Use (Hospitals, Laboratory, Home care, Others)

14.  Paraguay In Vitro Diagnostics Market Outlook

14.1.              Market Size & Forecast

14.1.1.  By Value

14.2.              Market Share & Forecast

14.2.1.  By Product (Instruments, Reagents, Software)

14.2.2.  By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

14.2.3.  By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

14.2.4.  By End Use (Hospitals, Laboratory, Home care, Others)

15.  Uruguay In Vitro Diagnostics Market Outlook

15.1.              Market Size & Forecast

15.1.1.  By Value

15.2.              Market Share & Forecast

15.2.1.  By Product (Instruments, Reagents, Software)

15.2.2.  By Technology (Immunoassay, Hematology, Clinical chemistry, Molecular diagnostics, Coagulation, Microbiology, Others)

15.2.3.  By Application (Infectious diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others)

15.2.4.  By End Use (Hospitals, Laboratory, Home care, Others)

16.  Market Dynamics

16.1.              Drivers

16.2.              Challenges

17.  Market Trends & Developments

17.1.              Recent Development

17.2.              Mergers & Acquisitions

17.3.              Product Launches

18.  Porter’s Five Forces Analysis

18.1.              Competition in the Industry

18.2.              Potential of New Entrants

18.3.              Power of Suppliers

18.4.              Power of Customers

18.5.              Threat of Substitute Products

19.  Competitive Landscape

19.1.              Business Overview

19.2.              Product Offerings

19.3.              Recent Developments

19.4.              Financials (As Reported)

19.5.              Key Personnel

19.6.              SWOT Analysis

19.6.1.   Becton Dickinson & Co Ltd

19.6.2.   BIOMÉRIEUX SA

19.6.3.   Abbott Laboratories Inc

19.6.4.   Quidel Corp

19.6.5.   OraSure Technologies, Inc.

19.6.6.   Hologic Inc

19.6.7.   Cepheid

19.6.8.   QIAGEN NV

19.6.9.   F Hoffmann-La Roche AG

19.6.10.  Siemens Healthcare GmbH

19.6.11.  Bio-Rad Laboratories Inc

20.   Strategic Recommendations

21. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the South America In Vitro Diagnostics Market was estimated to be USD 5.93 billion in 2022.

down-arrow

Becton Dickinson & Co Ltd, BIOMÉRIEUX SA, Abbott Laboratories Inc, Quidel Corp, OraSure Technologies, Inc., Hologic Inc, Cepheid, QIAGEN NV, F Hoffmann-La Roche AG, Siemens Healthcare GmbH, Bio-Rad Laboratories Inc are some of the key players operating in the South America In Vitro Diagnostics Market.

down-arrow

Economic disparities, limited healthcare budgets, cultural and language diversity, are some of the major challenges faced by the South America In Vitro Diagnostics Market in the upcoming years.

down-arrow

Rising population and healthcare needs favorable government policies are the major drivers for the South America In Vitro Diagnostics Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

South America In Vitro Diagnostics Market to Grow with a CAGR of 1.42% through 2028

Dec, 2023

An increase in aging population and research & development are expected to drive the South America In Vitro Diagnostics Market growth in the forecast period, 2024-2028.

Why Choose Us